Chronic medical conditions as risk factors for herpes zoster

Mayo Clinic Proceedings

Volumn 87, Issue 10, 2012, Pages 961-967

  Joesoef, Riduan M ^a   Harpaz, Rafael ^a   Leung, Jessica ^a   Bialek, Stephanie R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLERGIC RHINITIS; ARTICLE; ATTRIBUTABLE RISK; CANCER CHEMOTHERAPY; CASE CONTROL STUDY; CELLULAR IMMUNITY; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FACTUAL DATABASE; FEMALE; GOUT; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; ORGAN TRANSPLANTATION; OSTEOARTHRITIS; POPULATION RESEARCH; PREVALENCE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VARICELLA ZOSTER VIRUS; VIRUS LOAD; HEALTH STATUS; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEALTH STATUS; HERPES ZOSTER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

EID: 84871857399     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.05.021     Document Type: Article

References (32)

1. Schmader K. Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med. 2007;23(3):615-632.
2. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341-1349.
3. Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52(3):332-340.
4. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995;155(15):1605-1609.
5. Dworkin RH, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis. 2003;36(7):877-882.
6. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271- 2284.
7. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep. 2008;57(RR-5):1-30.
8. Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med. 1999;130(11):922-932.
9. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology. 1980;30(6):582-587.
10. Grote V, von Kries R, Rosenfeld E, Belohradsky BH, Liese J. Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis. 2007; 196(10):1455-1458.
11. Medco Health Solution, Inc. Medication Nation: Research finds chronic health problems now afflict more than half of all Americans. http://medco.mediaroom.com/index.php?s-17872&item- 27977. Accessed August 19, 2011.
12. Heymann AD, Chodick G, Karpati T, et al. Diabetes as a risk factor for herpes zoster infection: results of a populationbased study in Israel. Infection. 2008;36(3):226-230.
13. Smitten AL, Choi HK, Hochberg MC, et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 2007;57(8):1431-1438.
14. Strangfeld A, Listing J, Herzer P, et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA. 2009;301(7):737-744.
15. Irwin M, Costlow C, Williams H, et al. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis. 1998;178(suppl 1):S104-S108.
16. Livengood JM. The role of stress in the development of herpes zoster and postherpetic neuralgia. Curr Rev Pain. 2000;4(1):7-11.
17. Schmader K, George LK, Burchett BM, Pieper CF. Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis. 1998;178(suppl 1):S67-S70.
18. Dworkin RH, Banks SM. A vulnerability-diathesis-stress model of chronic pain: herpes zoster and the development of postherpetic neuralgia. In: Gatchel RJ, Turk DC, eds. Psychological Factors in Pain: Critical Practices. New York, NY: Guilford Press; 1999:247-269.
19. Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and noninflammatory musculoskeletal disorders. Rheumatology (Oxford). 2006;45(11):1370-1375.
20. Thompson Healthcare Inc. MarketScan Databases User Guide and Database Dictionary, Commercial and Medicare Supplemental Databases, 2006 Edition. Englewood, CO: Thompson Healthcare Inc; 2007.
21. Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748-753.
22. Thomson Healthcare. Red Book: Pharmacy's Fundamental Reference. Greenwood Village, CO: Thomson Reuters (Healthcare) Inc; 2008.
23. Deyo YA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
24. Rothman KJ, Greenland S, Lash TL. Applications of Stratified Analysis Methods: Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:283-302.
25. Levine B. What does the population attributable-fraction mean? http://www.cdc.gov/PCD/issues/2007/jan/06-0091.HTM. Accessed July 19, 2010.
26. Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009;27(6):882-887.
27. Virnig BA, McBean M. Administrative data for public health surveillance and planning. Annu Rev Public Health. 2001;22:213-230.
28. McDonald JR, Zeringue AL, Caplan L, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009;48(10):1364-1371.
29. Bearelly S, Mruthyunjaya P, Tzeng JP, et al. Identification of patients with diabetic macular edema from claims data: a validation study. Arch Ophthalmol. 2008;126(7):986-989.
30. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99-104.
31. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination- associated decreases in the incidence of varicella, 1992- 2002. J Infect Dis. 2005;191(12):2002-2007.
32. Ahmed F, Janes GR, Baron R, Latts LM. Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions. J Clin Epidemiol. 2005;58(6):624-628.